icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 13 八月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

在数字政府管理局注册,编号:

20250831619
建议

Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study

Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study

icon 2025-03-16
داعم الدراسة
King Abdullah International Medical Research Center’s (KAIMRC)
دواء الدراسة
Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine
رقم بروتوكول الدراسة
RJ19/119/J
حالة الدراسة
Ongoing
موقع الدراسة
King Abdullah Medical Complex (Jeddah)
مرحلة الدراسة
2